Beta-blockers in treatment of hypertension.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D004983:Ethanolamines / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000008:administration & dosage / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D007741:Labetalol